Xia, Weibo
Liu, Qiang
Lv, Jinhan
Zhang, Zhenlin
Wu, Wen
Xie, Zhongjian
Chen, Jianting
He, Liang
Dong, Jian
Hu, Zhenming
Lin, Qiang
Yu, Wei
Wei, Fang
Wang, Jue
Funding for this research was provided by:
Merck Sharp & Dohme China, Shanghai, China
Article History
Received: 17 December 2021
Accepted: 22 August 2022
First Online: 7 September 2022
Declarations
:
: The study followed the International Conference on Harmonization and Good Pharmacoepidemiology Practice (GPP), the Declaration of Helsinki, and applicable local regulatory guidance. Independent ethics committees of all sites approved the study before any study-related procedure.
: None.